Skip to main content
Premium Trial:

Request an Annual Quote

Veritas Genetics MyGenome

Veritas Genomics has launched myGenome, which the company claims is the world's first whole genome for less than $1,000, including interpretation and genetic counseling. Veritas first made $999 whole genome sequencing available to nearly 5,000 participants in the Personal Genome Project at Harvard Medical School. Veritas myGenome sequencing is performed in a CLIA laboratory, includes genetic counseling for clinically relevant conditions, and requires a physician order. The company said it is building a platform for myGenome that will include a secure digital report and app, access to a patient's genome data, on-demand genetic counseling, lifestyle-relevant genetic information, access to physicians, and omics data integration. This service is currently available for pre-orders in the US and other countries will be added in the coming months, the company said.

The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.